Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Carter

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Journal of Biological Response Modifiers|December 1, 1986
Serum protein masking of the thermal sensitivity of the antiviral activity of purified human beta interferon: implications for clinical studiesA W Cook, F Nidzgorski, P Came, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analoguesJ M Zarling, J Schlais, L Eskra, et al.
Progress in Clinical and Biological Research|January 1, 1985
Ampligen treatment of renal cell carcinoma: changes in 2-5A synthetase, 2-5A oligomer size and natural killer cell activity associated with antitumor response clinicallyR J Suhadolnik, N L Reichenbach, C Lee, et al.
Journal of Medical Virology|January 1, 1977
Pharmacologic effects of polyinosinic-polycytidylic acid in manA I Freeman, N Al-Bussam, J A O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1978
Enhancement of T cell cytotoxic responses by purified human fibroblast interferonJ M Zarling, J Sosman, L Eskra, et al.
Journal of Molecular Biology|October 14, 1972
Structural requirements of the rI n -rC n complex for induction of human interferonW A Carter, P M Pitha, L W Marshall, et al.
International Journal of Immunopharmacology|January 1, 1991
Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV diseaseW A Carter, D Ventura, D E Shapiro, et al.
The Journal of Biological Chemistry|July 25, 1974
Selective binding of human interferon to albumin immoblized on agaroseJ W Huang, M W Davey, C J Hejna, et al.
Texas Reports on Biology and Medicine|January 1, 1981
Clinical studies with mismatched double-stranded RNAD R Strayer, W A Carter, I Brodsky, et al.
In Vivo (Athens, Greece)|May 1, 1994
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elementsD Gillespie, H R Hubbell, W A Carter, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Journal of Biological Response Modifiers|December 1, 1986
Serum protein masking of the thermal sensitivity of the antiviral activity of purified human beta interferon: implications for clinical studiesA W Cook, F Nidzgorski, P Came, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1980
Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analoguesJ M Zarling, J Schlais, L Eskra, et al.
Progress in Clinical and Biological Research|January 1, 1985
Ampligen treatment of renal cell carcinoma: changes in 2-5A synthetase, 2-5A oligomer size and natural killer cell activity associated with antitumor response clinicallyR J Suhadolnik, N L Reichenbach, C Lee, et al.
Journal of Medical Virology|January 1, 1977
Pharmacologic effects of polyinosinic-polycytidylic acid in manA I Freeman, N Al-Bussam, J A O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1978
Enhancement of T cell cytotoxic responses by purified human fibroblast interferonJ M Zarling, J Sosman, L Eskra, et al.
Journal of Molecular Biology|October 14, 1972
Structural requirements of the rI n -rC n complex for induction of human interferonW A Carter, P M Pitha, L W Marshall, et al.
International Journal of Immunopharmacology|January 1, 1991
Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV diseaseW A Carter, D Ventura, D E Shapiro, et al.
The Journal of Biological Chemistry|July 25, 1974
Selective binding of human interferon to albumin immoblized on agaroseJ W Huang, M W Davey, C J Hejna, et al.
Texas Reports on Biology and Medicine|January 1, 1981
Clinical studies with mismatched double-stranded RNAD R Strayer, W A Carter, I Brodsky, et al.
In Vivo (Athens, Greece)|May 1, 1994
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elementsD Gillespie, H R Hubbell, W A Carter, et al.
Pageof 13